Esperion Therapeutics
Price & Volume
Stats
See moreOpen | $3.54 |
Previous Close | $3.55 |
Day Range | $3.00-$3.54 |
52W Range | $0.69-$4.17 |
Market Cap | $919.8M |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $303.8M |
Revenue Growth (YoY) | 69.1% |
Gross Profit (12 Mos) | $131.8M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • last month
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Familial Hypercholesterolemia Market Intelligence Report 2025-2035 Featuring Regeneron, Amgen, Esperion, Aegerion, Novartis and Other Key Players - Precision Medicine Fuels Personalized Treatment Approaches
Yahoo Finance • 2 months ago
Esperion a new overweight at Piper Sandler on CV franchise
Yahoo Finance • 2 months ago
Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia
About
CEO | Mr. Sheldon L. Koenig M.B.A. |
Address | 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 304 |
